• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神病领域移动健康干预措施的特征与结果:系统映射综述

Characteristics and Outcomes of mHealth Interventions in Psychosis: Systematic Mapping Review.

作者信息

Loh Pei Yi, Martinengo Laura, Heaukulani Creighton, Tan Xin Yang, Hng Moses, Cheah Yong Yin, Morris Robert J T, Tudor Car Lorainne, Lee Jimmy

机构信息

Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.

Centre for Behavioural and Implementation Sciences Interventions, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

出版信息

J Med Internet Res. 2024 Dec 23;26:e55924. doi: 10.2196/55924.

DOI:10.2196/55924
PMID:39714907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11704647/
Abstract

BACKGROUND

Mobile health (mHealth) interventions have gained popularity in augmenting psychiatric care for adults with psychosis. Interest has grown in leveraging mHealth to empower individuals living with severe mental illness and extend continuity of care beyond the hospital to the community. However, reported outcomes have been mixed, likely attributed in part to the intervention and adopted outcomes, which affected between-study comparisons.

OBJECTIVE

This study aimed to critically review outcome measures used to evaluate mHealth interventions for adults with psychosis in relation to the characteristics of mHealth interventions.

METHODS

A systematic mapping review was conducted. We searched PubMed, CINAHL, Embase, PsycINFO, and Cochrane Libraries from 1973 to the present. Selection criteria included randomized controlled studies of mHealth interventions in adults diagnosed with schizophrenia spectrum disorders. Reviewers worked in pairs to screen and extract data from included studies independently using a standardized form; disagreements were resolved by consensus with an independent reviewer. We report our findings in line with PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) guidelines.

RESULTS

A total of 1703 citations were screened; 29 publications reporting on 23 studies were included in this review. mHealth interventions for psychosis span a wide range, with psychological therapy being the most-deployed intervention (12/23, 52%), followed by psychoeducation (8/23, 35%) and active self-monitoring (8/23, 35%). Several mHealth interventions for psychosis targeted multiple pillars of biopsychosocial well-being (10/23, 43%); the bulk of interventions (16/23, 70%) incorporated features promoting users' self-management. The majority of mHealth interventions were delivered through applications (14/23, 61%) as the main medium and smartphones (17/23, 74%) as the main channel of delivery. Interventions were primarily administered in the outpatient and community settings (16/23, 70%); many were also blended with in-person sessions (11/23, 48%) or guided remotely (6/23, 26%) by persons, including health care providers or trained peer supporters. The severity of psychosis-related symptoms (21/23, 91%) was the most prevalent outcome, of which positive symptoms (13/23, 57%), mood and anxiety (10/23, 43%), and overall psychopathology severity (9/23, 39%) were most commonly measured. Patient-centric outcomes, including well-being (17/23, 74%)-particularly quality of life (10/23, 43%)-and user experience (15/23, 65%), including feasibility (7/23, 30%), acceptability (7/23, 30%), and engagement (7/23, 26%). Notably, outcome choices remained diverse despite stratification by type of mHealth intervention.

CONCLUSIONS

mHealth interventions for psychosis encompass a wide range of modalities and use outcome measures that probe various social and behavioral determinants of health. These should be considered complex interventions, and a holistic evaluation approach combining clinical and patient-centric outcomes is recommended.

摘要

背景

移动健康(mHealth)干预措施在增强对成年精神病患者的精神科护理方面越来越受欢迎。利用移动健康来增强严重精神疾病患者的能力并将护理的连续性从医院扩展到社区的兴趣日益浓厚。然而,报告的结果参差不齐,这可能部分归因于干预措施和采用的结果,这影响了研究间的比较。

目的

本研究旨在严格审查用于评估针对成年精神病患者的移动健康干预措施的结果指标,并结合移动健康干预措施的特点进行分析。

方法

进行了一项系统映射综述。我们检索了1973年至今的PubMed、CINAHL、Embase、PsycINFO和Cochrane图书馆。选择标准包括针对被诊断患有精神分裂症谱系障碍的成年人的移动健康干预措施的随机对照研究。评审人员成对工作,使用标准化表格独立筛选和提取纳入研究的数据;分歧通过与独立评审人员达成共识来解决。我们按照PRISMA-ScR(系统评价和Meta分析扩展的范围综述的首选报告项目)指南报告我们的研究结果。

结果

共筛选了1703条引文;本综述纳入了29篇报告23项研究的出版物。针对精神病的移动健康干预措施范围广泛,心理治疗是应用最广泛的干预措施(12/23,52%),其次是心理教育(8/23,35%)和主动自我监测(8/23,35%)。一些针对精神病的移动健康干预措施针对生物心理社会福祉的多个方面(10/23,43%);大部分干预措施(16/23,70%)包含促进用户自我管理的功能。大多数移动健康干预措施通过应用程序(14/23,61%)作为主要媒介和智能手机(17/23,74%)作为主要传递渠道来实施。干预措施主要在门诊和社区环境中进行(16/23,70%);许多干预措施还与面对面会议相结合(11/23,48%)或由包括医疗保健提供者或经过培训的同伴支持者在内的人员进行远程指导(6/23,26%)。与精神病相关症状的严重程度(21/23,91%)是最普遍的结果,其中阳性症状(13/23,57%)、情绪和焦虑(10/23,43%)以及整体精神病理学严重程度(9/23,39%)是最常测量的。以患者为中心的结果,包括幸福感(17/23,74%)——特别是生活质量(10/23,43%)——以及用户体验(15/23,65%),包括可行性(7/23,30%)、可接受性(7/23,30%)和参与度(7/23,26%)。值得注意的是,尽管按移动健康干预措施的类型进行了分层,但结果选择仍然多种多样。

结论

针对精神病的移动健康干预措施涵盖了广泛的模式,并使用了探究健康的各种社会和行为决定因素的结果指标。这些应被视为复杂的干预措施,建议采用结合临床和以患者为中心的结果的整体评估方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8339/11704647/5783ebbd458c/jmir_v26i1e55924_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8339/11704647/7a2fb504d106/jmir_v26i1e55924_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8339/11704647/780942e088d3/jmir_v26i1e55924_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8339/11704647/5783ebbd458c/jmir_v26i1e55924_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8339/11704647/7a2fb504d106/jmir_v26i1e55924_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8339/11704647/780942e088d3/jmir_v26i1e55924_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8339/11704647/5783ebbd458c/jmir_v26i1e55924_fig3.jpg

相似文献

1
Characteristics and Outcomes of mHealth Interventions in Psychosis: Systematic Mapping Review.精神病领域移动健康干预措施的特征与结果:系统映射综述
J Med Internet Res. 2024 Dec 23;26:e55924. doi: 10.2196/55924.
2
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review.低强度心理干预在预防抑郁复发中的临床效果和成本效益:系统评价。
Health Technol Assess. 2012 May;16(28):1-130. doi: 10.3310/hta16280.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
6
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
8
Early intervention for psychosis.精神病的早期干预
Cochrane Database Syst Rev. 2006 Oct 18(4):CD004718. doi: 10.1002/14651858.CD004718.pub2.
9
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
10
Educational interventions for the management of cancer-related fatigue in adults.针对成人癌症相关疲劳管理的教育干预措施。
Cochrane Database Syst Rev. 2016 Nov 24;11(11):CD008144. doi: 10.1002/14651858.CD008144.pub2.

引用本文的文献

1
E-Mental Health Interventions in Inpatient Care: Scoping Review.住院护理中的电子心理健康干预措施:范围综述
J Med Internet Res. 2025 Jul 31;27:e65947. doi: 10.2196/65947.
2
Mobile Therapeutic Attention for Treatment-Resistant Schizophrenia (m-RESIST) Solution for Improving Clinical and Functional Outcomes in Treatment-Resistant Schizophrenia: Prospective, Multicenter Efficacy Study.用于难治性精神分裂症的移动治疗关注(m-RESIST)方案:改善难治性精神分裂症临床和功能结局的前瞻性多中心疗效研究
JMIR Hum Factors. 2025 May 15;12:e67659. doi: 10.2196/67659.

本文引用的文献

1
An overview of and recommendations for more accessible digital mental health services.更易获取的数字心理健康服务概述与建议。
Nat Rev Psychol. 2022 Feb;1(2):87-100. doi: 10.1038/s44159-021-00003-1. Epub 2022 Jan 26.
2
Negative symptoms in the clinic: we treat what we can describe.临床中的阴性症状:我们治疗我们能够描述的症状。
Br J Psychiatry. 2023 Jul;223(1):271-272. doi: 10.1192/bjp.2023.68. Epub 2023 Jul 10.
3
A Smartphone App to Promote Patient Activation and Support Shared Decision-making in People With a Diagnosis of Schizophrenia in Outpatient Treatment Settings (Momentum Trial): Randomized Controlled Assessor-Blinded Trial.
一款用于促进精神分裂症门诊治疗患者积极性和支持共同决策的智能手机应用程序(Momentum 试验):随机对照评估者盲法试验。
J Med Internet Res. 2022 Oct 26;24(10):e40292. doi: 10.2196/40292.
4
The Economic Burden of Schizophrenia in the United States.美国精神分裂症的经济负担。
J Clin Psychiatry. 2022 Oct 10;83(6):22m14458. doi: 10.4088/JCP.22m14458.
5
Effects of a Metacognitive Smartphone Intervention With Weekly Mentoring Sessions for Individuals With Schizophrenia: A Quasi-Experimental Study.元认知智能手机干预联合每周辅导对精神分裂症个体的效果:一项准实验研究。
J Psychosoc Nurs Ment Health Serv. 2023 Feb;61(2):27-37. doi: 10.3928/02793695-20220706-01. Epub 2022 Jul 12.
6
Human-Centered Design Approaches in Digital Mental Health Interventions: Exploratory Mapping Review.数字心理健康干预中的以人为本设计方法:探索性映射综述
JMIR Ment Health. 2022 Jun 7;9(6):e35591. doi: 10.2196/35591.
7
Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCT.数字化智能手机干预识别和管理精神分裂症早期预警信号以预防复发:EMPOWER 可行性聚类 RCT。
Health Technol Assess. 2022 May;26(27):1-174. doi: 10.3310/HLZE0479.
8
Relapse prevention through health technology program reduces hospitalization in schizophrenia.通过健康技术项目预防复发可减少精神分裂症患者的住院治疗。
Psychol Med. 2023 Jul;53(9):4114-4120. doi: 10.1017/S0033291722000794. Epub 2022 May 30.
9
The EMPOWER blended digital intervention for relapse prevention in schizophrenia: a feasibility cluster randomised controlled trial in Scotland and Australia.在苏格兰和澳大利亚开展的 EMPOWER 混合数字干预预防精神分裂症复发的可行性聚类随机对照试验。
Lancet Psychiatry. 2022 Jun;9(6):477-486. doi: 10.1016/S2215-0366(22)00103-1.
10
Digital Health Interventions for Delivery of Mental Health Care: Systematic and Comprehensive Meta-Review.用于提供精神卫生保健的数字健康干预措施:系统全面的元综述
JMIR Ment Health. 2022 May 12;9(5):e35159. doi: 10.2196/35159.